Esophageal cancer in Northeastern Iran: A review

Archives of Iranian Medicine

Volumn 10, Issue 1, 2007, Pages 70-82

  Kamangar, Farin ^a   Malekzadeh, Reza ^b   Dawsey, Sanford M ^a   Saidi, Farrokh ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Esophageal cancer; Iran

Indexed keywords

ALCOHOL DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 2; CYTOCHROME P450 1A1; CYTOCHROME P450 2A6; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; NITROSO DERIVATIVE; OPIATE; POLYCYCLIC AROMATIC HYDROCARBON; PROTEIN P53; SELENIUM; SILICON DIOXIDE; ZINC;

ALCOHOL CONSUMPTION; CANCER INCIDENCE; CANCER RESEARCH; CARCINOGENESIS; CIGARETTE SMOKING; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; ESOPHAGUS CANCER; FLUID INTAKE; FRUIT; GENE MUTATION; GENETIC POLYMORPHISM; HEREDITY; HORSEBACK RIDING; HUMAN; IRAN; MOUTH HYGIENE; NUTRITIONAL DEFICIENCY; OPIATE ADDICTION; PERIODONTAL DISEASE; REVIEW; SELENIUM DEFICIENCY; SOCIAL STATUS; SQUAMOUS CELL CARCINOMA; VEGETABLE; WART VIRUS; ZINC DEFICIENCY;

CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HUMANS; INCIDENCE; IRAN; RURAL POPULATION;

EID: 33846687592     PISSN: 10292977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (112)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics 2002. CA Cancer J Chn. 2005; 55: 74-108.
2. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006; 24: 2137-2150.
3. Brown LM, Devesa SS. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am. 2002; 11: 235-256.
4. Ke L. Mortality and incidence trends from esophagus cancer in selected geographic areas of China circa 1970-1990. Int J Cancer. 2002; 102: 271-274.
5. Mahboubi E, Kmet J, Cook PJ, Day NE, Ghadirian P, Salmasizadeh S. Oesophageal cancer studies in the Caspian littoral of Iran: the Caspian cancer registry. Br J Cancer. 1973; 28: 197-214.
6. Habibi A. Cancer in Iran. A survey of the most common cases. J Natl Cancer Inst. 1965; 34: 553-569.
7. Habibi A. Cancer in Iran. Statistical review on 28,000 cases. Pathol Microbiol (Basel). 1970; 35: 181-183.
8. Barekat AA, Saidi F, Dutz W. Cancer survey in South Iran with special reference to gastrointestinal neoplasms. Int J Cancer. 1971; 7: 353-363.
9. Haghighi P, Nasr K. Gastrointestinal cancer in Iran. J Chronic Dis. 1971; 24: 625-633.
10. Haghighi P, Nabizadeh I, Asvadi S, Mohallatee EA. Cancer in southern Iran. Cancer. 1971; 27: 965-977.
11. Kmet J, Mahboubi E. Esophageal cancer in the Caspian littoral of Iran: initial studies. Science. 1972; 175: 846-853.
12. Hormozdiari H, Day NE, Aramesh B, Mahboubi E. Dietary factors and esophageal. cancer in the Caspian littoral of Iran. Cancer Res. 1975; 35: 3493-3498.
13. Joint Iran-Intemational Agency for Research on Cancer Study Group. Esophageal cancer studies in the Caspian littoral of Iran: results of population studies - a prodrome. J Natl Cancer Inst. 1977; 59: 1127-1138.
14. Cook-Mozaffari PJ, Azordegan F, Day NE, Ressicaud A, Sabai C, Aramesh B. Oesophageal cancer studies in the Caspian littoral of Iran: results of a case-control study. Br J Cancer. 1979; 39: 293-309.
15. Dowlatshahi K, Daneshbod A, Mobarhan S. Early detection of cancer of oesophagus along Caspian littoral. Report of a pilot project. Lancet. 1978; 1: 125-126.
16. Crespi M, Munoz N, Grassi A, Aramesh B, Amiri G, Mojtabai A, et al. Oesophageal lesions in northern Iran: a premalignant condition? Lancet. 1979; 2: 217-221.
17. Hewer T, Rose E, Ghadirian P, Castegnaro M, Malaveille C, Bartsch H, et al. Ingested mutagens from opium and tobacco pyrolysis products and cancer of the oesophagus. Lancet. 1978; 2: 494-496.
18. Malaveille C, Friesen M, Camus AM, Garren L, Hautefeuille A, Bereziat JC, et al. Mutagens produced by the pyrolysis of opium and its alkaloids as possible risk factors in cancer of the bladder and oesophagus. Carcinogenesis. 1982; 3: 577-585.
19. Ghadirian P, Stein GF, Gorodetzky C, Roberfroid MB, Mahon GA, Bartsch H, et al. Oesophageal cancer studies in the Caspian littoral of Iran: some residual results, including opium use as a risk factor. Int J Cancer. 1985; 35: 593-597.
20. Ghadirian P. Familial history of esophageal cancer. Cancer. 1985; 56: 2112-2116.
21. Ghadirian P. Thermal irritation and esophageal cancer in northern Iran. Cancer. 1987; 60: 1909-1914.
22. Saidi F, Sepehr A, Fahimi S, Farahvash MJ, Salehian P, Esmailzadeh A, et al. Oesophageal cancer among the Turkomens of North-East Iran. Br J Cancer. 2000; 83: 1249-1254.
23. Sepehr A, Razavi P, Saidi F, Salehian P, Rahmani M, Shamshiri A. Esophageal exfoliative cytology samplers. A comparison of three types. Acta Cytol. 2000; 44: 797-804.
24. Sepehr A, Kamangar F, Fahimi S, Saidi F, Abnet CC, Dawsey SM. Poor oral health as a risk factor for esophageal squamous dysplasia in northeastern Iran. Anticancer Res. 2005; 25: 543-546.
25. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst. 1993; 85: 1483-1492.
26. Tran GD, Sun XD, Abnet CC, Fan JH, Dawsey SM, Dong ZW, et al. Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China. Int J Cancer. 2005; 113: 456-463.
27. Saenko AI. The epidemiology of cancer in Central Asia. Vopr Onkol. 1975; 21: 40-44.
28. Zaridze DG, Basieva T, Kabulov M, Day NE, Duffy SW. Oesophageal cancer in the Republic of Karakalpakstan. Int J Epidemiol. 1992; 21: 643-648.
29. Kairakbaev MK. Malignant neoplasms among ethnic groups in the Kazakh SSR. Vopr Onkol. 1978; 24: 100-104.
30. Islami F, Kamangar F, Aghcheli K, Fahimi S, Semnani S, Taghavi N, et al. Epidemiologic features of upper gastrointestinal tract cancer in northeastern Iran. Br J Cancer. 2004; 90: 1402-1406.
31. Semnani S, Sadjadi A, Fahimi S, Nouraic M, Naeimi M, Kabir J, et al. Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian littoral of Iran: a retrospective cancer surveillance. Cancer Detect Prev. 2006; 30: 14-19.
32. He YT, Hou J, Qiao CY, Chen ZF, Song GH, Li SS, et al. An analysis of esophageal cancer incidence in Cixian county from 1974 to 1996. World J Gastroenterol. 2003; 9: 209-213.
33. Tuyns AJ. Oesophageal cancer in nonsmoking drinkers and in nondrinking smokers. Int J Cancer. 1983; 32: 443-444.
34. Brown LM, Hoover RN, Greenberg RS, Schoenberg JB, Schwartz AG, Swanson GM, et al. Are racial differences in squamous cell esophageal cancer explained by alcohol and tobacco use? J Natl Cancer Inst. 1994; 86: 1340-1345.
35. Brown LM, Hoover R, Silverman D, Baris D, Hayes R, Swanson GM, et al. Excess incidence of squamous cell esophageal cancer among U.S. Black men: role of social class and other risk factors. Am J Epidemiol. 2001; 153: 114-122.
36. Abnet CC, Qiao YL, Mark SD, Dong ZW, Taylor PR, Dawsey SM. Prospective study of tooth loss and incident esophageal and gastric cancers in China. Cancer Causes Control. 2001; 12: 847-854.
37. Pourshams A, Saadatian-Elahi M, Nouraie M, Fazeltabar A, Rakhshani N, Salahi R, et al. Golestan cohort study of oesophageal cancer: feasibility and first results. Br J Cancer. 2004; 92: 176-181.
38. Jensen OM. Cancer morbidity and causes of death among Danish brewery workers. Int J Cancer. 1979; 23: 454-463.
39. Boffetta P, Garfinkel L. Alcohol drinking and mortality among men enrolled in an American Cancer Society prospective study. Epidemiology. 1990; 1: 342-348.
40. Perry PE, Thomson EJ, Vijayalaxm I, Evans HJ, Day NE, Bartsch H. Induction of SCE by opium pyrolysates in CHO cells and human peripheral blood lymphocytes. Carcinogenesis. 1983; 4: 227-230.
41. Friesen M, O'Neill IK, Malaveille C, Garren L, Hautefeuille A, Cabral JR, et al. Characterization and identification of 6 mutagens in opium pyrolysates implicated in oesophageal cancer in Iran. Mutat Res. 1985; 150: 177-191.
42. Abnet CC, Saadatian-Elahi M, Pourshams A, Boffetta P, Feizzadeh A, Brennan P, et al. Reliability and validity of opiate use self-report in a population at high risk for esophageal cancer in Golestan, Iran. Cancer Epidemiol Biomarkers Prev. 2004; 13: 1068-1070.
43. De Jong UW, Day NE, Mounier-Kuhn PL, Haguenauer JP. The relationship between the ingestion of hot coffee and intraoesophageal temperature. Gut. 1972; 13: 24-30.
44. Castellsague X, Munoz N, De Stefani E, Victora CG, Castelletto R, Rolon PA. Influence of mate drinking, hot beverages, and diet on esophageal cancer risk in South America. Int J Cancer. 2000; 88: 658-664.
45. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer. 1999; 80: 827-841.
46. Castelletto R, Castellsague X, Munoz N, Iscovich J, Chopita N, Jmelnitsky A. Alcohol, tobacco, diet, mate drinking, and esophageal cancer in Argentina. Cancer Epidemiol Biomarkers Prev. 1994; 3: 557-564.
47. Rolon PA, Castellsague X, Benz M, Munoz N. Hot and cold mate drinking and esophageal cancer in Paraguay. Cancer Epidemiol Biomarkers Prev. 1995; 4: 595-605.
48. Sewram V, DeStefani E, Brennan P, Boffetta P. Mate consumption and the risk of squamous cell esophageal cancer in Uruguay. Cancer Epidemiol Biomarkers Prev. 2003; 12: 508-513.
49. De Stefani E, Munoz N, Esteve J, Vasallo A, Victora CG, Teuchmann S. Mate drinking, alcohol, tobacco, diet, and esophageal cancer in Uruguay. Cancer Res. 1990; 50: 426-431.
50. Fagundes RB, Abnet CC, Strickland PT, Kamangar F, Roth MJ, Taylor PR, et al. Higher urine 1-hydroxy pyrene glucuronide (1-OHPG) is associated with tobacco smoke exposure and drinking mate in healthy subjects from Rio Grande do Sul, Brazil. BMC Cancer. 2006; 6: 139.
51. Segi M. Tea-gruel as a possible factor for cancer for the esophagus. Gann. 1975; 66: 199-202.
52. De Jong UW, Breslow N, Hong JG, Sridharan M, Shanmugaratnam K. Aetiological factors in oesophageal cancer in Singapore Chinese. Int J Cancer. 1974; 13: 291-303.
53. Martinez I. Factors associated with cancer of the esophagus, mouth, and pharynx in Puerto Rico. J Natl Cancer Inst. 1969; 42: 1069-1094.
54. Gammon MD, Schoenberg JB, Ahsan H, Risch HA, Vaughan TL, Chow WH, et al. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1997; 89: 1277-1284.
55. Jansson C, Johansson AL, Nyren O, Lagergren J. Socioeconomic factors and risk of esophageal adenocarcinoma: a nationwide Swedish case-control study. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1754-1761.
56. Menvielle G, Luce D, Geoffroy-Perez B, Chastang JF, Leclerc A. Social inequalities and cancer mortality in France, 1975-1990. Cancer Causes Control. 2005; 16: 501-513.
57. Tuyns AJ, Riboli E, Doornbos G, Pequignot G. Diet and esophageal cancer in Calvados (France). Nutr Cancer. 1987; 9: 81-92.
58. Gao YT, McLaughlin JK, Gridley G, Blot WJ, Ji BT, Dai Q, et al. Risk factors for esophageal cancer in Shanghai, China. II. Role of diet and nutrients. Int J Cancer. 1994; 58: 197-202.
59. Tzonou A, Lipworth L, Garidou A, Signorello LB, Lagiou P, Hsieh C, et al. Diet and risk of esophageal cancer by histologic type in a low-risk population. Int J Cancer. 1996; 68: 300-304.
60. Launoy G, Milan C, Day NE, Pienkowski MP, Gignoux M, Faivre J. Diet and squamous-cell cancer of the oesophagus: a French multicenter case-control study. Int J Cancer. 1998; 76: 7-12.
61. Yang CX, Wang HY, Wang ZM, Du HZ, Tao DM, Mu XY, et al. Risk factors for esophageal cancer: a case-control study in southwestern China. Asian Pac J Cancer Prev. 2005; 6: 48-53.
62. Guo W, Blot WJ, Li JY, Taylor PR, Liu BQ, Wang W, et al. A nested case-control study of oesophageal and stomach cancers in the Linxian nutrition intervention trial. Int J Epidemiol. 1994; 23: 444-450.
63. Gonzalez CA, Pera G, Agudo A, Bueno-de-Mesquita HB, Ceroti M, Boeing H, et al. Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer. 2006; 118: 2559-2566.
64. Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruits and vegetables on cancer risk. Am J Clin Nutr. 2003; 78 (3 suppl): 559S-69S.
65. Knekt P, Aromaa A, Maatela J, Alfthan G, Aaran RK, Hakama M, et al. Serum selenium and subsequent risk of cancer among Finnish men and women. J Natl Cancer Inst. 1990; 82: 864-868.
66. Mark SD, Qiao YL, Dawsey SM, Wu YP, Katki H, Gunter EW, et al. Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst. 2000; 92: 1753-1763.
67. Wei WQ, Abnet CC, Qiao YL, Dawsey SM, Dong ZW, Sun XD, et al. Prospective study of serum selenium concentrations and esophageal and gastric cardia cancers, heart disease, stroke, and total death. Am J Clin Nutr. 2004; 79: 80-85.
68. Nouarie M, Pourshams A, Kamangar F, Sotoudeh M, Derakhshan MH, Akbari MR, et al. Ecologic study of serum selenium and upper gastrointestinal cancers in Iran. World J Gastroenterol. 2004; 10: 2544-2546.
69. Fong LY, Magee PN. Dietary zinc deficiency enhances esophageal cell proliferation and N-nitrosomethyl-benzylamine (NMBA)-induced esophageal tumor incidence in C57BL/6 mouse. Cancer Lett. 1999; 143: 63-69.
70. Fong LY, Sivak A, Newberne PM. Zinc deficiency and methylbenzylnitrosamine-induced esophageal cancer in rats. J Natl Cancer Inst. 1978; 61: 145-150.
71. Abnet CC, Lai B, Qiao YL, Vogt S, Luo XM, Taylor PR, et al. Zinc concentration in esophageal biopsy specimens measured by X-ray fluorescence and esophageal cancer risk. J Natl Cancer Inst. 2005; 97: 301-306.
72. Hecht SS. Carcinogen biomarkers for lung or oral cancer chemoprevention trials. IARC Sci Publ. 2001; 154: 245-255.
73. Roth M, Qiao Y, Rothman N, Tangrea J, Dawsey S, Wang G, et al. High urine 1-hydroxypyrene glucoronide concentration in Linxian, China, an area of high risk for squamous oesophageal cancer. Biomarkers. 2001; 6: 381-386.
74. Roth MJ, Guo-Qing W, Lewin KJ, Ning L, Dawsey SM, Wesley MN, et al. Histopathologic changes seen in esophagectomy specimens from the high-risk region of Linxian, China: potential clues to an etiologic exposure? Hum Pathol. 1998; 29: 1294-1298.
75. Roth MJ, Strickland KL, Wang GQ, Rothman N, Greenberg A, Dawsey SM. High levels of carcinogenic polycyclic aromatic hydrocarbons present within food from Linxian, China may contribute to that region's high incidence of oesophageal cancer. Eur J Cancer. 1998; 34: 757-758.
76. Kamangar F, Strickland PT, Pourshams A, Malekzadeh R, Boffetta P, Roth MJ, et al. High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran. Anticancer Res. 2005; 25: 425-428.
77. Fong LY, Lau KM, Huebner K, Magee PN. Induction of esophageal tumors in zinc-deficient rats by single low doses of N-nitrosomethylbenzylamine (NMBA): analysis of cell proliferation, and mutations in H-ras and p53 genes. Carcinogenesis. 1997; 18: 1477-1484.
78. Lijinsky W, Kovatch RM. Induction of liver tumors in rats by nitrosodiethanolamine at low doses. Carcinogenesis. 1985; 6: 1679-1681.
79. Ivankovic S, Seibel J, Komitowski D, Spiegelhalder B, Preussmann I, Siddiqi M. Caffeine-derived N-nitroso compounds. V. Carcinogenicity of mononitrosocaffeidine and dinitrosocaffeidine in bd-ix rats. Carcinogenesis. 1998; 19: 933-937.
80. Preussmann R, Habs M, Habs H, Stummeyer D. Fluoro-substituted N-nitrosamines. 6. Carcinogenicity of N-nitroso-(2,2,2-trifluoroethyl)-ethylamine in rats. Carcinogenesis. 1983; 4: 755-757.
81. Bartsch H, Spiegelhalder B. Environmental exposure to N-nitroso compounds (NNOC) and precursors: an overview. Eur J Cancer Prev. 1996; 5 (suppl 1): 11-17.
82. Tricker AR. N-nitroso compounds and man: sources of exposure, endogenous formation and occurrence in body fluids. Eur J Cancer Prev. 1997; 6: 226-228.
83. Forman D. Dietary exposure to N-nitroso compounds and the risk of human cancer. Cancer Surv. 1987; 6: 719-738.
84. Mirvish SS. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal, and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett. 1995; 93: 17-48.
85. Mirvish SS. The etiology of gastric cancer. Intragastric nitrosamide formation and other theories. J Natl Cancer Inst. 1983; 71: 629-647.
86. Abnet CC, Kamangar F, Dawsey SM, Stolzenberg-Solomon RZ, Albanes D, Pietinen P, et al. Tooth loss is associated with increased risk of gastric noncardia adenocarcinoma in a cohort of Finnish smokers. Scand J Gastroenterol. 2005; 40: 681-687.
87. Lin K, Shen W, Shen Z, Wu Y, Lu S. Dietary exposure and urinary excretion of total N-nitroso compounds, nitrosamino acids, and volatile nitrosamine in inhabitants of high- and low-risk areas for esophageal cancer in southern China. Int J Cancer. 2002; 102: 207-211.
88. Jakszyn P, Gonzalez CA. Nitrosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence. World J Gastroenterol. 2006; 12: 4296-4303.
89. Eisenbrand G, Spiegelhalder B, Preussmann R. Nitrate and nitrite in saliva. Oncology. 1980; 37: 227-231.
90. O'Neill CH, Hodges GM, Riddle PN, Jordan PW, Newman RH, Flood RJ, et al. A fine fibrous silica contaminant of flour in the high oesophageal cancer area of North-East Iran. Int J Cancer. 1980; 26: 617-628.
91. O'Neill C, Pan Q, Clarke G, Liu F, Hodges G, Ge M, et al. Silica fragments from millet bran in mucosa surrounding oesophageal tumors in patients in northern China. Lancet. 1982; 1: 1202-1206.
92. Pan G, Takahashi K, Feng Y, Liu L, Liu T, Zhang S, et al. Nested case-control study of esophageal cancer in relation to occupational exposure to silica and other dusts. Am J Ind Med. 1999; 35: 272-280.
93. Steenland Y, Sanderson W. Lung cancer among industrial sand workers exposed to crystalline silica. Am J Epidemiol. 2001; 153: 695-703.
94. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillornavirus types associated with cervical cancer. N Engl J Med. 2003; 348: 518-527.
95. Gillison ML, Shah KV. Chapter 9: Role of mucosal human papillomavirus in nongenital cancers. J Natl Cancer Inst Monogr. 2003; 31: 57-65.
96. Syrjanen KJ. HPV infections and oesophageal cancer. J Clin Pathol. 2002; 55: 721-728.
97. Kamangar F, Qiao YL, Schiller JT, Dawsey SM, Fears T, Sun XD, et al. Human papillomavirus serology and the risk of esophageal and gastric cancers: results from a cohort in a high-risk region in China. Int J Cancer. 2006; 119: 579-584.
98. Dillner J, Knekt P, Schiller JT, Hakulinen T. Prospective seroepidemiological evidence that human papillomavirus type 16 infection is a risk factor for oesophageal squamous cell carcinoma. BMJ. 1995; 311: 1346.
99. Bjorge T, Hakulinen T, Engeland A, Jellum E, Koskela P, Lehtinen M, et al. A prospective, seroepidemiological study of the role of human papillomavirus in esophageal cancer in Norway. Cancer Res. 1997; 57: 3989-3992.
100. Han C, Qiao G, Hubbert NL, Li L, Sun C, Wang Y, et al. Serologic association between human papillomavirus type 16 infection and esophageal cancer in Shaanxi Province, China. J Natl Cancer Inst. 1996; 88: 1467-1471.
101. Lagergren J, Wang Z, Bergstrom R, Dillner J, Nyren O. Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden. J Natl Cancer Inst. 1999; 91: 156-162.
102. van Doornum GJ, Korse CM, Buning-Kager JC, Bonfrer JM, Horenblas S, Taal BG, et al. Reactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sites. Br J Cancer. 2003; 88: 1095-1100.
103. Farhadi M, Tahmasebi Z, Merat S, Kamangar F, Nasrollahzadeh D, Malekzadeh R. Human papillomavirus in squamous cell carcinoma of esophagus in a high-risk population. World J Gastroenterol. 2005; 11: 1200-1203.
104. Abnet CC, Qiao YL, Dawsey SM, Dong ZW, Taylor PR, Mark SD. Tooth loss is associated with increased risk of total death and death from upper gastrointestinal cancer, heart disease, and stroke in a Chinese population-based cohort. Int J Epidemiol. 2005; 34: 467-474.
105. Demirer T, Icli F, Uzunalimoglu O, Kucuk O. Diet and stomach cancer incidence. A case-control study in Turkey. Cancer. 1990; 65: 2344-2348.
106. Watabe K, Nishi M, Miyake H, Hirata K. Lifestyle and gastric cancer: a case-control study. Oncol Rep. 1998; 5: 1191-1194.
107. Sepehr A, Taniere P, Martel-Planche G, Zia'ee AA, Rastgar-Jazii F, Yazdanbod M, et al. Distinct pattern of TP53 mutations in squamous cell carcinoma of the esophagus in Iran. Oncogene. 2001; 20: 7368-7374.
108. Yang CX, Matsuo K, Wang ZM, Tajima K. Phase I/II enzyme gene polymorphisms and esophageal cancer risk: meta-analysis of the literature. World J Gastroenterol. 2005; 11: 2531-2538.
109. Lewis SJ, Smith GD. Alcohol, ALDH2, and esophageal cancer: a meta-analysis which illustrates the potentials and limitations of a Mendelian randomization approach. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1967-1971.
110. Yokoyama A, Omori T. Genetic polymorphisms of alcohol and aldehyde dehydrogenases and risk for esophageal and head and neck cancers. Jpn J Clin Oncol. 2003; 33: 111-121.
111. Sepehr A, Kamangar F, Abnet CC, Fahimi S, Pourshams A, Poustchi H, et al. Genetic polymorphisms in three Iranian populations with different risks of esophageal cancer, an ecologic comparison. Cancer Lett. 2004; 213: 195-202.
112. Urisman A, Molinaro RJ, Fischer N, Plummer SJ, Casey G, Klein EA, et al. Identification of a novel gammaretrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog. 2006;2:e25.